A. M. Joensen et al.
446
Fig. 2b AFEQT
3
6
Month after baseline
Control
CI
9
0
12
3
6
Month after baseline
Control
CI
Treatment
Fig. 2c GAD-7
9
12
Treatment
Fig. 2d PHQ-9
0
0
Fig. 2a AF_QOL
3
6
Month after baseline
Control
CI
9
12
0
Treatment
3
6
Month after baseline
Control
CI
9
12
Treatment
Fig. 2e EQVAS
0
3
6
Month after baseline
Control
CI
9
12
Treatment
until 6 months. The maximum O 2 uptake increased
from 29.0 ml O 2 /kg (SD 7.3) at baseline to 31.1 (SD
7.4) after 6 months.
In the 5RSS test, the rehabilitation group improved
during the first 3 months and remained approximately
the same for the next 3 months. The control group
remained at the same level during the first 3 months
but improved from 3 to 6 months. Thus, the difference
www.medicaljournals.se/jrm
Fig. 2a–e. Quality of life (QoL) scores (using 5 different QoL
questionnaires) for patients with atrial fibrillation (AF) randomized
to participate in a 12-week multifaceted rehabilitation programme vs
usual care at 3, 6 and 12 months after inclusion in the study. Shown
with 95% confidence intervals (95% CI). (a) Quality of Life in patients
with Atrial Fibrillation (AF-QoL) (b) Atrial Fibrillation Effect on QualiTy
of Life (AFEQT:) (c) Generalised Anxiety Disorder Assessment (GAD-
7) (d) Patient Health Questionnaire (PHQ-9); (e) visual analogue
scale (EQVAS).
between the 2 groups was the same at 6 months as at
baseline (Fig. 3 and Table III).
In the 6MW test, the baseline mean distance was
similar between groups. A small improvement was
observed in both groups from baseline to 6 months, but
no statistically significant difference between groups.
Nine patients had AF during one or more of the
physical tests. Stratification for AF or sinus rhythm did